author-photo

Thomas A. Wadden

University of Pennsylvania

552

Papers

48606

Citations

Citation Trend

Filter By

Papers (552) Sort By

Journal Conference Others

Abstract #1003901: Once-Weekly Subcutaneous Semaglutide 2.4 mg Plus Intensive Behavioral Therapy Produces Clinically Meaningful Weight Loss in Adults with Overweight/Obesity Regardless of Baseline Characteristics and Weight History

2021 Endocrine Practice
Show All
- Source
- Cite
- Save
Citations (0)
3 Efficacy and Safety of Semaglutide 2.4 mg Once-Weekly in Adults With Overweight or Obesity and Type 2 Diabetes (STEP 2)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Questionnaire on Eating and Weight Patterns-5

2021
Show All
- Source
- Cite
- Save
Citations (2)
Changes in the Prevalence of Symptoms of Depression, Loneliness, and Insomnia in U.S. Older Adults With Type 2 Diabetes During the COVID-19 Pandemic: The Look AHEAD Study.

2021 Diabetes Care
Show All
- Source
- Cite
- Save
Citations (0)
Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)

2021 Journal of the Endocrine Society
Show All
- Source
- Cite
- Save
Citations (0)
Dietary interventions for obesity: clinical and mechanistic findings.

2021 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (3)
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss.

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (52)
Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)

2021 Journal of the Endocrine Society
Show All
- Source
- Cite
- Save
Citations (1)
5 Weight-Loss Maintenance with Once-Weekly Semaglutide 2.4 mg in Adults with Overweight or Obesity Reaching Maintenance Dose (STEP 4)

2021
Show All
- Source
- Cite
- Save
Citations (0)